AstraZeneca sees pivotal lung cancer trial results later in 2018 [Reuters]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Reuters
AstraZeneca sees pivotal lung cancer trial results later in 2018 | Reuters Reuters Staff 1 Min Read LONDON (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half. The Phase III trial, known as Mystic, is testing Imfinzi on its own and in combination with tremelimumab, and the drugmaker noted in a brief statement on Monday that it was driven by clinical events among patients involved. First results from Mystic disappointed investors last July when AstraZeneca’s two drugs proved no more effective at stopping disease progression than chemotherapy, sending its shares tumbling. Reporting by Ben Hirschler, editing by Louise Heavens All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. AstraZeneca sees pivotal lung cancer trial results later in 2018 LONDON (Reuters) - AstraZeneca n
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- BenevolentAI Provides an Update on Its Business Priorities [Yahoo! Finance]Yahoo! Finance
- Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]Yahoo! Finance
- With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing [Yahoo! Finance]Yahoo! Finance
- Vaccines Market worth $65.3 billion by 2028: BCC Research LLC [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/8/24 - Form 6-K
- AZN's page on the SEC website